Concepedia

Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation

Mirjam K. de Vries, Steven O. Stapel, Henk de Vrieze, J. Christiaan van Denderen, B.A.C. Dijkmans, L Aarden, Irene van der Horst‐Bruinsma

Annals of the Rheumatic Diseases · 2007 · 155 citations · 11 references

DOIFull text

Open access

Concepts

References

11

Evaluation of Diagnostic Criteria for Ankylosing Spondylitis

Sjef van der Linden, Hans A. Valkenburg, A. Cats · Arthritis & Rheumatism · 1984 · 5.7K citations

, , +6

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

, , +12

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Sylvester Garrett, T Jenkinson, L G Kennedy et al. · PubMed · 1994 · 3.2K citations

, , +12

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Filip Baert, Maja Noman, Séverine Vermeire et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

, , +17

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

Désirée van der Heijde, Ben A. C. Dijkmans, Piet Geusens et al. · Arthritis & Rheumatism · 2005 · 861 citations

, , +14